FDA
-
-
-
-
-
-
-
Vivos partners with Florida cardiology group for sleep disorder treatment
-
-
-
-
-
-
-
Rafael Holdings completes phase 3 study for rare disease treatment
-
-
-
-
-
-
-
Summit Therapeutics announces $500 million stock offering
-
-
-
-
-
-
-
NeuroSense receives Japanese patent for ALS drug candidate PrimeC
-
-
-
-
-
-
-
SCIENTURE adds REZENOPY nasal spray to major health plan formulary
-
-
-
-
-
-
-
Cartesian Therapeutics partners with WestGene for in vivo CAR-T development
-
-
-
-
-
-
-
Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug
-
322,743 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

